Cancer clinical trials in the region Grand Est

174 currently recruiting clinical trials
Region Grand Est

Phase 1 / Phase 2 Endometrial cancer
#NCT04104776
Endometrioid adenocarcinoma Serous adenocarcinoma Clear cell carcinoma Dedifferentiated and undifferentiated endometrial ... Locally Advanced Metastatic ARID1A 1 2 3 or more
Systemic Treatment-Naive
ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg)
Constellation Pharmaceutique
Phase 1 / Phase 2 Lung cancer
#NCT04104776
Mesothelium Locally Advanced Metastatic Other mutation 1 2 3 or more
Systemic Treatment-Naive
ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg)
Constellation Pharmaceutique
Phase 1 / Phase 2 Pancreas cancer
#NCT05706129
Adenocarcinoma Locally Advanced Metastatic 1 2 3 or more Chemotherapy
CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy)
Debiopharm International SA
Phase 1 / Phase 2 Colon cancer Rectal cancer
#NCT05706129
Locally Advanced Metastatic 1 2 3 or more Chemotherapy Targeted therapy
CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy)
Debiopharm International SA
Phase 1 / Phase 2 Kidney cancer
#NCT05706129
Clear cell carcinoma Locally Advanced Metastatic 2 3 or more Targeted therapy Immunotherapy Targeted therapy
CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy)
Debiopharm International SA
Phase 1 / Phase 2 Kidney cancer
#NCT05706129
Other Localized None Systemic Treatment-Naive
CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy)
Debiopharm International SA
Phase 1 / Phase 2 Breast cancer Lung cancer
#NCT05706129
NSCLC (Non-Small Cell Lung Cancer) Squamous NSCLC HER2 Negative HR Negative Locally Advanced Metastatic 1 2 3 or more
Systemic Treatment-Naive
CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy)
Debiopharm International SA
Phase 1 / Phase 2 Lung cancer
#NCT04585750
Locally Advanced Metastatic TP53 1 2 3 or more
KRAS G12C KRAS non G12C Systemic Treatment-Naive
ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg)
PMV Pharmaceuticals, Inc
Phase 1 / Phase 2 Breast cancer
#NCT04585750
Locally Advanced Metastatic TP53 1 2 3 or more
KRAS G12C KRAS non G12C Systemic Treatment-Naive
ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg)
PMV Pharmaceuticals, Inc
Phase 1 / Phase 2 Prostate cancer
#NCT04585750
Metastatic Castration-resistant TP53 1 2 3 or more
KRAS G12C KRAS non G12C Systemic Treatment-Naive
ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg)
PMV Pharmaceuticals, Inc